meningococcal group B disease
Vaccines · 2013–2015
2decisions
2medicines
2carried consumer input
54individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| meningococcal group B vaccine, recombinant, adsorbed Active immunisation against disease caused by Neisseria meningitidis group B strains in infants and adolescents for prevention of meningococcal B disease. | Jul 2015 | Not recommended | 14 individuals |
| Meningococcal group B vaccine, 4-component Prevention of meningococcal B disease in infants and adolescents. Active immunisation against disease caused by Neisseria meningitidis group B strains in… | Nov 2013 | Not recommended | 40 individuals |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.